LADENBURG THALMANN FINANCIAL SERVICES INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2019$706,000
-0.1%
7,373
+20.0%
0.00%
-20.0%
Q3 2019$707,000
-18.8%
6,143
+21.7%
0.01%
-16.7%
Q2 2019$871,000
+13.9%
5,049
+11.3%
0.01%0.0%
Q1 2019$765,000
+90.3%
4,535
+10.3%
0.01%
+50.0%
Q4 2018$402,000
-35.3%
4,112
+13.9%
0.00%
-20.0%
Q3 2018$621,000
+80.5%
3,610
+18.1%
0.01%
+66.7%
Q2 2018$344,0000.0%3,0570.0%0.00%0.0%
Q1 2018$344,000
+6.8%
3,057
+25.4%
0.00%0.0%
Q4 2017$322,000
+9.5%
2,438
-15.6%
0.00%0.0%
Q3 2017$294,000
+51.5%
2,887
+49.5%
0.00%
+50.0%
Q2 2017$194,000
-17.1%
1,931
-0.8%
0.00%
-33.3%
Q1 2017$234,000
+7.3%
1,946
+1.6%
0.00%0.0%
Q4 2016$218,000
-7.2%
1,916
+8.0%
0.00%
-25.0%
Q3 2016$235,000
+30.6%
1,774
-9.9%
0.00%
+33.3%
Q2 2016$180,000
+27.7%
1,970
+0.5%
0.00%
+50.0%
Q1 2016$141,000
+15.6%
1,960
+12.3%
0.00%0.0%
Q4 2015$122,000
+23.2%
1,746
+62.1%
0.00%0.0%
Q3 2015$99,000
-41.4%
1,077
-21.6%
0.00%
-33.3%
Q2 2015$169,000
+32.0%
1,374
-1.5%
0.00%
+50.0%
Q1 2015$128,000
+814.3%
1,395
+554.9%
0.00%
Q4 2014$14,000
-63.2%
213
-54.7%
0.00%
-100.0%
Q3 2014$38,000
-65.1%
470
-53.9%
0.00%
-66.7%
Q2 2014$109,000
+808.3%
1,020
+410.0%
0.00%
Q1 2014$12,000
+50.0%
2000.0%0.00%
Q4 2013$8,0002000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders